Chaperonin Containing TCP1, Subunit 8 (Theta) (CCT8) (N-Term) Peptide
-
- Target See all CCT8 products
- CCT8 (Chaperonin Containing TCP1, Subunit 8 (Theta) (CCT8))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LKEGAKHFSG LEEAVYRNIQ ACKELAQTTR TAYGPNGMNK MVINHLEKLF
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CCT8 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CCT8 (Chaperonin Containing TCP1, Subunit 8 (Theta) (CCT8))
- Background
-
As a molecular chaperone, CCT8 assists the folding of proteins upon ATP hydrolysis. It is known to play a role, in vitro, in the folding of actin and tubulin.
Alias Symbols: C21orf112, Cctq, D21S246, PRED71
Protein Size: 548 - Molecular Weight
- 60 kDa
- Gene ID
- 10694
- NCBI Accession
- NM_006585, NP_006576
- UniProt
- P50990
-